The Indian pharmaceutical sector faces mixed growth with a 12% YoY and 5% QoQ rise while IPM growth is projected at 8%.

The Indian pharmaceutical industry is projected to experience a mixed quarter, with slower growth anticipated in the branded ...

This issue underscores the broader challenge of maintaining stringent quality controls in the pharmaceutical supply chain, ...

India's pharmaceutical and meditech exports are expected to continue strong growth despite global economic slowdown, driven ...

Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...

Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...

On 9 September the US House of Representatives passed the draft of the Biosecure Act, which aims to prohibit US pharma ...

Korean biopharmaceutical companies are exploring opportunities at Bio Japan 2024 amid U.S.-China tensions, with major firms ...

Messe Muenchen India successfully concluded its highly anticipated and largest edition of analytica Anacon India, India Lab ...

The current status of the Biosecure Act is that it was passed ​ by the US House of Representatives on Sep 9, with a vote of ...

As drug companies fret over their finances, they are increasingly partnering with universities to help with early-stage ...

Developing First-Class Medical Science Liaisons through Proficient On-Boarding and Continuous Training Programs" report has been added to ResearchAndMarkets.com's offering. This guide presents a ...